✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Alnylam Pharmaceuticals Inc

Common Name
Alnylam Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,500
Ticker
ALNY
Exchange
NASDAQ/NGS
Description
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing RNA interference (RNAi) therapeutics. This innovative gene silencing technology targets the root ca...
Data not available

No Climate Targets data disclosed by Alnylam Pharmaceuticals

We reviewed Alnylam Pharmaceuticals's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.